Joseph Geraci

Company: NetraMark Corp

Job title: Chief Technology Officer & Chief Scientific Officer

Seminars:

Panel Discussion: Evaluating Current Strategies for ALS Target Identification: What are the Avenues to Still Prioritise? 10:30 am

Outlining current avenues of disease pathology to identify and validate targets for familial and sporadic ALS Processing disease pathology information to validate genetic ALS targets Where are the current innovations for novel target identification?Read more

day: Day One AM